Gankyrin promotes breast cancer cell metastasis by regulating Rac1 activity

57Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Tumor metastasis is responsible for most cancer patients' deaths. Understanding the mechanism of metastasis is crucial for improving the cure rate for cancer. Here, we report that Gankyrin, a chaperone of ubiquitin-proteasome, has an essential role in breast cancer metastasis. We find that Gankyrin is highly overexpressed in human breast cancers and the expression correlates strongly with lymph node metastasis. Knocking down Gankyrin expression in highly metastatic human breast cancer cells significantly decreases cancer cell migration and invasion. Furthermore, we demonstrate that depletion of Gankyrin inhibits intrinsic Rac1 activity and induces large focal adhesions. Overexpression of Gankyrin accelerates focal adhesion turnover and increases cell migration. Notably, reduction of Gankyrin expression in mouse mammary tumor cell significantly decreases tumor metastasis to lung in animal models. Therefore, our findings suggest that Gankyrin is crucial for breast cancer metastasis and highlight the potential of Gankyrin as a therapeutic target for tumor metastasis. © 2013 Macmillan Publishers Limited All rights reserved.

Author supplied keywords

Cite

CITATION STYLE

APA

Zhen, C., Chen, L., Zhao, Q., Liang, B., Gu, Y. X., Bai, Z. F., … Man, J. H. (2013). Gankyrin promotes breast cancer cell metastasis by regulating Rac1 activity. Oncogene, 32(29), 3452–3460. https://doi.org/10.1038/onc.2012.356

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free